Read the full article in the Sept/Oct 2021 issue of Retina Specialist where Richard Mark Kirkner interviews Dr. Amir Kashani, about the technology and the clinical investigation.
Publication of the one year follow-up results from our Phase 1/2a clinical trial in dry age-related macular degeneration - In a Special Issue of Translational Vision Science & Technology (tvst)
Read the latest blog post (or listen on Spotify) profiling our program on THE STEM CELLAR, The Official Blog of CIRM, California's Stem Cell Agency.
In an article for UCSB - The Current, Britney Pennington and Lincoln Johnson discuss how novel cryopreservation methods enable long-term storage and worldwide distribution of a cellular therapy for age-related macular degeneration.
In a paper published in the journal Scientific Reports, RPT scientists in collaboration with colleagues at the University of California Santa Barbara and the University of Southern California report a novel cryopreservation technique that facilitates long-term storage of RPT’s CPCB-RPE1 ocular implants. This technique will greatly enhance the ability to widely distribute the implants and increase the number AMD patients that are able to receive the treatment.
Publication of preliminary results from our Phase 1/2a clinical trial in dry age-related macular degeneration - The cover story in Science Translational Medicine
AARP highlights RPT Study participant in: Saving Their Health and Ours. Medical Breakthroughs of 2020
A video produced by the Roski Eye Institute - highlighting the first implant procedure
A participant in our clinical trial shares her story.
RPT co-founder Dr. Dennis Clegg describes the recent strategies to develop a regenerative patch for the treatment of age-related macular degeneration by developing a cellular therapy using stem cells.
TEDx talk - Stemming Vision Loss with Stem Cells- RPT co-founder Dr. Dennis Clegg
Why There’s New Hope About Ending Blindness
Highlighted in the documentary Story of Sight
Development of a Bio-Engineered Implant for AMD Treatment
Dr. Jane Lebkowski shares her presentation from the virtual 2020 Cell & Gene Meeting on the Mesa, describing RPTs program and development our bio-engineered implant for the treatment of AMD
Pennington BO, Bailey JK, Faynus MA, Hinman C, Hee MN, Ritts R, Nadar V, Zhu D, Mitra D, Martinez-Camarillo JC, Lin TC, Thomas BB, Hinton DR, Humayun MS, Lebkowski J, Johnson LV, Clegg DO. Sci Rep. 2021 Mar 18;11(1):6286.
Kashani AH, Uang J, Mert M, Rahhal F, Chan C, Avery RL, Dugel P, Chen S, Lebkowski J, Clegg DO, Hinton DR, Humayun MS. Ophthalmol Retina. 2020 Mar;4(3):264-273.
Kashani AH, Martynova A, Koss M, Brant R, Zhu DH, Lebkowski J, Hinton D, Clegg D, Humayun MS.
Adv Exp Med Biol. 2019;1185:569-574.
Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin CM, Mitra D, Zhu D, Thomas BB, Hikita ST, Pennington BO, Johnson LV, Clegg DO, Hinton DR, Humayun MS. Sci Transl Med. 2018 Apr 4;10(435). pii: eaao4097.
Copyright © 2018 Regenerative Patch Technologies, LLC - All Rights Reserved.